A Randomised Trial Of Krill Oil For Osteoarthritis Of The Knee
Funder
National Health and Medical Research Council
Funding Amount
$751,491.00
Summary
This study trials krill oil vs placebo, for painful knee osteoarthritis in people with joint swelling on MRI scans, to assess if krill oil reduces knee pain and knee swelling over 24 weeks. If krill oil can delay loss of knee cartilage through effects on cartilage and bone, this this could lead to a delay in the time to knee replacement surgery and improvements in quality of life for those suffering from OA.
From Imaging To Intervention In Osteoarthritis And Back Pain
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
Osteoarthritis and back pain are regarded as cartilage disorders, however recent evidence suggests that underlying bone and joint fluid pathology are also involved. This project takes a unique approach of targeting bone and joint fluid pathology of knee osteoarthritis and back pain, and will test the effects of existing therapies and krill oil through clinical trials. If successful, it will have the potential to slow progression to joint replacement through an easy method of implementation.
DICKENS - A Randomised Controlled Trial Of DIaCerein To Treat KneE Osteoarthritis With EffusioN-Synovitis
Funder
National Health and Medical Research Council
Funding Amount
$1,327,836.00
Summary
Knee osteoarthritis (OA) is common, but the current treatments are poor. Almost 60% of people with knee OA have joint inflammation. Patients with inflammation are more likely to experience joint pain and rapid joint destruction. We propose that treating patients with inflammatory knee OA with the anti-inflammatory drug, diacerein, will reduce pain and joint damage.
Synovial Macrophages And T-cells Are Therapeutic Targets In Osteoarthritis
Funder
National Health and Medical Research Council
Funding Amount
$658,761.00
Summary
Osteoarthritis (OA) is the most widespread musculoskeletal disease in Australia and there are currently no therapies that halt disease progression. Specific inflammatory events play a pivotal role in initiating and driving OA progression. In this study we will define the specific inflammatory cells involved in OA, how and why they change with time, and which can be targeted to stop disease onset and development. This will provide the platform for initiating human clinical trials.